Sino Medical Sciences Technology Inc.

SHSE:688108 Stock Report

Market Cap: CN¥6.1b

Sino Medical Sciences Technology Future Growth

Future criteria checks 5/6

Sino Medical Sciences Technology is forecast to grow earnings and revenue by 77.6% and 26.8% per annum respectively. EPS is expected to grow by 77.4% per annum. Return on equity is forecast to be 6.6% in 3 years.

Key information

77.6%

Earnings growth rate

77.41%

EPS growth rate

Medical Equipment earnings growth22.3%
Revenue growth rate26.8%
Future return on equity6.64%
Analyst coverage

Low

Last updated23 Jun 2025

Recent future growth updates

No updates

Recent updates

Sino Medical Sciences Technology Inc.'s (SHSE:688108) Share Price Matching Investor Opinion

Jan 05
Sino Medical Sciences Technology Inc.'s (SHSE:688108) Share Price Matching Investor Opinion

Is Sino Medical Sciences Technology (SHSE:688108) Using Debt Sensibly?

Nov 19
Is Sino Medical Sciences Technology (SHSE:688108) Using Debt Sensibly?

Revenues Tell The Story For Sino Medical Sciences Technology Inc. (SHSE:688108) As Its Stock Soars 25%

Sep 24
Revenues Tell The Story For Sino Medical Sciences Technology Inc. (SHSE:688108) As Its Stock Soars 25%

What Sino Medical Sciences Technology Inc.'s (SHSE:688108) P/S Is Not Telling You

Jun 03
What Sino Medical Sciences Technology Inc.'s (SHSE:688108) P/S Is Not Telling You

Optimistic Investors Push Sino Medical Sciences Technology Inc. (SHSE:688108) Shares Up 26% But Growth Is Lacking

Mar 05
Optimistic Investors Push Sino Medical Sciences Technology Inc. (SHSE:688108) Shares Up 26% But Growth Is Lacking

Is Sino Medical Sciences Technology (SHSE:688108) Using Debt In A Risky Way?

Feb 28
Is Sino Medical Sciences Technology (SHSE:688108) Using Debt In A Risky Way?

Earnings and Revenue Growth Forecasts

SHSE:688108 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202798299N/A751
12/31/202674454N/A431
12/31/202557718N/A-481
3/31/2025469666145N/A
12/31/2024459161131N/A
9/30/2024417-9170N/A
6/30/2024396-7254N/A
3/31/2024361-25-161N/A
12/31/2023343-40-1157N/A
9/30/2023272-95-88-4N/A
6/30/2023244-121-155-47N/A
3/31/2023207-149-184-88N/A
12/31/2022193-162-222-111N/A
9/30/2022239-129-183-66N/A
6/30/2022226-120-210-84N/A
3/31/2022226-119-226-70N/A
12/31/2021194-131-219-60N/A
9/30/2021173-138-217-59N/A
6/30/2021230-90-1355N/A
3/31/2021283-27-9039N/A
12/31/202032722-4271N/A
9/30/2020401731152N/A
6/30/202040474-19153N/A
3/31/202040775-24139N/A
12/31/201943690-42138N/A
9/30/201941991-3598N/A
12/31/201838089N/A98N/A
12/31/201732266N/A70N/A
12/31/201626629N/A42N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688108's forecast earnings growth (77.6% per year) is above the savings rate (2.7%).

Earnings vs Market: 688108's earnings (77.6% per year) are forecast to grow faster than the CN market (23.6% per year).

High Growth Earnings: 688108's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688108's revenue (26.8% per year) is forecast to grow faster than the CN market (12.6% per year).

High Growth Revenue: 688108's revenue (26.8% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688108's Return on Equity is forecast to be low in 3 years time (6.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/04 09:51
End of Day Share Price 2025/08/04 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sino Medical Sciences Technology Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuo SongCitic Securities Co., Ltd.
Ziran GuCitic Securities Co., Ltd.
Zhuo HuangEverbright Securities Co. Ltd.